Mediheal is turning a historic winning streak in South Korea into fresh momentum in the U.S. skincare market, after being named the No. 1 brand in total sales at Olive Young for two consecutive years (2024–2025) , ahead of more than 3,000 competing brands.
Widely described as the Korean equivalent of Ulta or Sephora, Olive Young has become a proving ground for K beauty brands with real global potential and Mediheal’s performance there is now accelerating its international expansion. Record breaking wins at
Olive Young At the latest Olive Young Awards , Mediheal took home four major honors, underscoring its dominance across key skincare formats. The brand was awarded No.
1 in the Toner Pad category, Global Trend Best Performer for the Madecassoside Blemish Pad, Global Trend Rising for the Madecassoside Blemish Serum , and Winner in the Mask category with the Madecassoside Essential Sheet Mask . Within this lineup, the Madecassoside Blemish Pad ranked No.
1 in its category for the second year in a row, while the Madecassoside Blemish Repair Serum posted an 820% year on year sales jump, cementing madecassoside as a hero ingredient for the brand. These results help explain why Mediheal has secured the No.
1 mask ranking for 15 consecutive years at Olive Young , alongside more than 3.3 billion sheet masks sold worldwide and over 32 million toner pads sold globally. From Korean bestseller to U.S. Amazon breakout The same formulas driving Mediheal’s success in Korea are now showing traction with U.S. consumers…
